J E Bubbers

791 total citations
26 papers, 676 citations indexed

About

J E Bubbers is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, J E Bubbers has authored 26 papers receiving a total of 676 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 10 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Molecular Biology. Recurrent topics in J E Bubbers's work include Monoclonal and Polyclonal Antibodies Research (8 papers), Virus-based gene therapy research (6 papers) and T-cell and B-cell Immunology (6 papers). J E Bubbers is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (8 papers), Virus-based gene therapy research (6 papers) and T-cell and B-cell Immunology (6 papers). J E Bubbers collaborates with scholars based in United States. J E Bubbers's co-authors include Christopher S. Henney, F Lilly, C S Henney, Marshall Plaut, Edward M. Messing, John L. Fahey, Jean B. deKernion, Kenneth J. Blank, Robert W. Rand and Richard A. Steeves and has published in prestigious journals such as Nature, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

J E Bubbers

26 papers receiving 549 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J E Bubbers United States 15 379 202 156 102 67 26 676
Jack H. Stimpfling United States 13 690 1.8× 268 1.3× 196 1.3× 149 1.5× 74 1.1× 26 1.0k
P Liacopoulos France 14 398 1.1× 282 1.4× 232 1.5× 87 0.9× 37 0.6× 102 789
H. U. Schwenk Germany 6 314 0.8× 311 1.5× 54 0.3× 64 0.6× 142 2.1× 13 705
Bruce Merchant United States 17 416 1.1× 315 1.6× 414 2.7× 78 0.8× 245 3.7× 55 993
Helmut M. Sassenfeld United States 12 740 2.0× 507 2.5× 269 1.7× 133 1.3× 231 3.4× 16 1.3k
Jacques Roland France 13 828 2.2× 328 1.6× 294 1.9× 91 0.9× 129 1.9× 34 1.2k
Elisabeth Thomassen United States 13 495 1.3× 766 3.8× 118 0.8× 171 1.7× 91 1.4× 14 1.2k
A S Rosenthal United States 10 325 0.9× 460 2.3× 124 0.8× 168 1.6× 40 0.6× 15 923
Matko Cikes Sweden 11 306 0.8× 202 1.0× 89 0.6× 77 0.8× 111 1.7× 17 606
Gerald N. Callahan United States 14 1.2k 3.1× 245 1.2× 264 1.7× 179 1.8× 182 2.7× 37 1.6k

Countries citing papers authored by J E Bubbers

Since Specialization
Citations

This map shows the geographic impact of J E Bubbers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J E Bubbers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J E Bubbers more than expected).

Fields of papers citing papers by J E Bubbers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J E Bubbers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J E Bubbers. The network helps show where J E Bubbers may publish in the future.

Co-authorship network of co-authors of J E Bubbers

This figure shows the co-authorship network connecting the top 25 collaborators of J E Bubbers. A scholar is included among the top collaborators of J E Bubbers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J E Bubbers. J E Bubbers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wiśniewski, Marcin, et al.. (1993). Inhibition of lipopolysaccharide-associated endotoxin activities in vitro and in vivo by the human anti-lipid A monoclonal antibody SdJ5-1.17.15. Infection and Immunity. 61(9). 3873–3878. 7 indexed citations
2.
Dorai, Haimanti, et al.. (1992). Cloning and Reexpression of a Functional Human IgM Anti-Lipid A Antibody. Hybridoma. 11(5). 667–675. 9 indexed citations
3.
Messing, Edward M., J E Bubbers, Kristene Whitmore, et al.. (1984). Murine Hybridoma Antibodies Against Human Transitional Carcinoma-Associated Antigens. The Journal of Urology. 132(1). 167–172. 21 indexed citations
4.
Bubbers, J E. (1984). Identification and Linkage Analyses of a Gene, <italic>Rcs-1</italic>, Suppressing Spontaneous SJL/J Lymphoma Expression<xref ref-type="fn" rid="FN2">2</xref>. JNCI Journal of the National Cancer Institute. 72(2). 441–6. 9 indexed citations
5.
Messing, Edward M., J E Bubbers, Jean B. deKernion, & John L. Fahey. (1984). Growth Stimulating Activity Produced by Human Bladder Cancer Cells. The Journal of Urology. 132(6). 1230–1234. 13 indexed citations
6.
Juillard, G & J E Bubbers. (1983). Experimental intralymphatic immunotherapy (ILI) of canine allergic disease. Federation Proceedings. 42(3). 441. 5 indexed citations
8.
Silberman, Allan W., F. Kristian Storm, Robert W. Rand, et al.. (1982). Localized magnetic‐loop induction hyperthermia of the rabbit brain. Journal of Surgical Oncology. 20(3). 174–178. 22 indexed citations
9.
Silberman, Allan W., et al.. (1982). An experimental brain tumor model in rabbits. Journal of Surgical Oncology. 20(4). 218–220. 7 indexed citations
10.
Messing, Edward M., John L. Fahey, Jean B. deKernion, Sunita Bhuta, & J E Bubbers. (1982). Serum-free medium for the in vitro growth of normal and malignant urinary bladder epithelial cells.. PubMed. 42(6). 2392–7. 19 indexed citations
11.
Bubbers, J E & F Lilly. (1978). Anti-Friend virus antibody-induced resistance of Friend virus-infected spleen cells to lysis mediated by anti-H-2 antisera.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 38(9). 2722–8. 11 indexed citations
12.
Steeves, Richard A., J E Bubbers, Fernando Plata, & F Lilly. (1978). Origin of spleen colonies generated by Friend virus-infected cells in mice.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 38(9). 2729–33. 16 indexed citations
13.
Bubbers, J E, et al.. (1978). Nonrandom inclusion of H-2K and H-2D antigens in Friend virus particles from mice of various strains.. The Journal of Experimental Medicine. 147(2). 340–351. 62 indexed citations
14.
Bubbers, J E, et al.. (1977). Mechanisms of the H‐2 Effect on Viral Leukemogenesis. Scandinavian Journal of Immunology. 6(5). 533–539. 28 indexed citations
15.
Bubbers, J E, Richard A. Steeves, & F Lilly. (1976). Evidence for a physical association between friend virus-induced and histocompatibility antigens on leukemia cell surfaces. Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 93. 4 indexed citations
16.
Plaut, Marshall, J E Bubbers, & Christopher S. Henney. (1976). Studies on the Mechanism of Lymphocyte-Mediated Cytolysis. The Journal of Immunology. 116(1). 150–155. 39 indexed citations
17.
Plaut, Marshall, J E Bubbers, & C S Henney. (1976). Studies of the mechanism of lymphocyte-mediated cytolysis. VII. Two stages in the T cell-mediated lytic cycle with distinct cation requirements.. PubMed. 116(1). 150–5. 56 indexed citations
18.
Bubbers, J E & Christopher S. Henney. (1975). Studies on the Synthetic Capacity and Antigenic Expression of Glutaraldehyde-Fixed Target Cells. The Journal of Immunology. 114(3). 1126–1131. 47 indexed citations
19.
Bubbers, J E & Christopher S. Henney. (1975). Studies on the Mechanism of Lymphocyte-Mediated Cytolysis. The Journal of Immunology. 115(1). 145–149. 16 indexed citations
20.
Henney, Christopher S. & J E Bubbers. (1973). Studies on the Mechanism of Lymphocyte-Mediated Cytolysis. The Journal of Immunology. 110(1). 63–72. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026